COMMUNIQUÉS West-GlobeNewswire

Aptevo Therapeutics’ Bispecific Antibody APVO436 Shows Robust T-Cell Activation With Minimal Cytokine Release
16/04/2018
New Preclinical Data Presented at the 2018 American Association for Cancer Research Annual Meeting Show Potent T-Cell Directed Tumor Killing with Reduced Cytokine Production Compared to a Competitor Bispecific Construct [...]
OrthoPediatrics Corp. Honored as One of the Best Places to Work in Indiana for a Second Year
16/04/2018
WARSAW, Ind., April 16, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS ), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce that it was recently named as [...]
Leap Therapeutics Presents Nonclinical and Clinical Data on DKN-01 at AACR 2018 Annual Meeting
16/04/2018
CAMBRIDGE, Mass., April 16, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ: LPTX ) today presented nonclinical and clinical data on DKN-01, Leap’s anti-DKK1 monoclonal antibody, at the American Association for [...]
Biothera Pharmaceuticals Presents Translational Data from Ongoing Clinical Trials Showing Imprime PGG in Combination with Merck’s KEYTRUDA® (pembrolizumab) Drives Innate and Adaptive Immune Responses in Tumors
16/04/2018
EAGAN, Minn., April 16, 2018 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals, Inc. today announced the presentation of new translational data from ongoing phase 2 clinical trials combining Biothera’s Imprime PGG with [...]
TESARO Summarizes TSR-042 Clinical Data Presented at AACR
16/04/2018
Activity of TSR-042 (anti-PD-1 antibody) monotherapy demonstrated in patients with MSI-high endometrial and non-small cell lung cancers Data support unique and convenient dosing schedule Regulatory submission for TSR- [...]
SELLAS Life Sciences Reports Corporate Highlights, Advancements for its Cancer Immunotherapy Pipeline and 2017 Financial Results
16/04/2018
NEW YORK, April 16, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group Inc. (Nasdaq: SLS ) (“SELLAS”), a clinical-stage biopharmaceutical company focused on novel cancer immunotherapies for a broad range of cancer [...]
Endocyte Presents Data from its CAR T Platform at American Association for Cancer Research (AACR) Annual Meeting 2018
16/04/2018
Late-breaking poster demonstrates EC17/CAR T-cell therapy showed consistent antitumor activity in human xenografts with multiple mechanisms for controlling immune response WEST LAFAYETTE, Ind., April 16, 2018 (GLOBE [...]
BeiGene Presents Clinical Data on Pamiparib in Chinese Patients with Ovarian Cancers or Triple-Negative Breast Cancer at the American Association for Cancer Research Annual Meeting
16/04/2018
BEIJING, China and CAMBRIDGE, Mass., April 16, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly [...]
VBL Therapeutics Presents Late Breaking Research Demonstrating Immune-cell Mediated Killing of Cancer Cells by a Novel Bi-specific Antibody at AACR
16/04/2018
TEL AVIV, Israel, April 16, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ: VBLT ) today presented a late-breaking study demonstrating a novel bi-specific antibody that induces immune-cell mediated killing of cancer [...]
Advantis Corp. Increased Revenue Over Eight Fold in 2017, Expects Revenue to Rise
16/04/2018
NEWPORT BEACH, CA , April 16, 2018 (GLOBE NEWSWIRE) -- ADVANTIS CORPORATION (OTC PINK: ADVT) released its annual financial report, revealing the revenue increase of a company on the rise. 2017 revenue was $406,000 vs. $ [...]
Cannabix Technologies Files FAIMS Cannabis Detection Patent - Enters into License Agreement with University of Florida and Provides Technology Update
16/04/2018
The Cannabix Marijuana Breathalyzer is being developed to give law enforcement and employers a tool to enforce public safety VANCOUVER, British Columbia, April 16, 2018 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. ( [...]
Regalia® CG Biofungicide Cleared for Use on Cannabis by the Colorado, Oregon, Washington and Nevada Departments of Agriculture
16/04/2018
Trials Show Regalia® CG to be an Effective Method of Powdery Mildew Control in Cannabis and Hemp DAVIS, Calif., April 16, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider [...]
Kallelse till årsstämma för C-RAD AB (publ)
16/04/2018
Aktie ä garna i C-RAD AB (publ), org. nr 556663-9174 ( ” Bolaget ” ), kallas h ä rmed till å rsst ä mma torsdagen den 17 maj 2018 klockan 10.00 p å Clarion Hotel Gillet, Dragarbrunnsgatan 23 i Uppsala. Rätt att deltaga [...]
AIT Therapeutics Names Stephen J. DiPalma as Chief Financial Officer
16/04/2018
Industry veteran brings over 30 years of experience to AIT NEW YORK, April 16, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTC:AITB), a clinical-stage medical device and biopharmaceutical company focused on [...]
Alder BioPharmaceuticals® Appoints Erin Lavelle to Newly Created Role of Chief Operating Officer
16/04/2018
Continues to Build Executive Team and Position Company for Next Stage of Growth and Development BOTHELL, Wash., April 16, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR ) (“Alder” or the “Company [...]
Cerner to Release First Quarter 2018 Earnings Results May 2
16/04/2018
KANSAS CITY, Mo. , April 16, 2018 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN ) today announced it will release its first quarter 2018 earnings results after the market closes Wednesday, May 2. Following the [...]
Organovo Achieves Key Development Milestones for Its Liver Disease and Intestinal Tissue Models
16/04/2018
SAN DIEGO, April 16, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO ) (“Organovo”) today announced that along with its collaborators, it has achieved several breakthrough capabilities for its 3D [...]
Cellectar Presents Preclinical Data at AACR Annual Meeting Demonstrating the Ability of its PDCs to Selectively Target a Broad Range of Tumor Cells
16/04/2018
MADISON, Wis., April 16, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment [...]
Galectin Therapeutics Late-Breaker Presentation at The International Liver Congress Reinforces and Extends the Positive Effects of GR-MD-02 in Patients With NASH Cirrhosis
16/04/2018
NORCROSS, Ga., April 16, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT ), the leading developer of therapeutics that target galectin proteins, today provided highlights from a late-breaker oral [...]

Pages